Nilotinib

• ATC Code
• Indication
• NEMLC Recommendation
• Review Indicators
• Date Ratified

ATC CODE

• L01XE08

INDICATION

• Chronic Myeloid Leukemia in patients resistant or intolerant to imatinib.

NEMLC RECOMMENDATION

• Approved

REVIEW INDICATORS

• Longer term follow-up of nilotinib versus imatinib showing clinical benefits in the first line.
• Reduction in cost or availability of nilotinib generics.

DATE RATIFIED

• 22 January 2015